Evidence map›Paper›PMID 35563478›Full record

ReviewInternational journal of molecular sciences2022

Functions and Mechanisms of Pro-Lysyl Oxidase Processing in Cancers and Eye Pathologies with a Focus on Diabetic Retinopathy.

Philip C Trackman, Yaser Peymanfar, Sayon Roy

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. IGF-II regulates lysyl oxidase propeptide and mediates its effects in part via basic helix-loop-helix E40.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Multifunctional Lysyl Oxidases.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Philip C TrackmanThe Forsyth Institute, 245 First Street, Cambridge, MA 02142, USA.ORCID 0000-0001-5064-614X
Yaser PeymanfarThe Forsyth Institute, 245 First Street, Cambridge, MA 02142, USA.ORCID 0000-0002-5793-0474
Sayon RoyDepartment of Medicine, Boston University School of Medicine, 650 Albany Street, Boston, MA 02118, USA.
Boston University · US

Funding

Role of Abnormal lysyl oxidase in the pathogenesis of diabetic retinopathyR01EY025528 · NEI · BOSTON MEDICAL CENTER · PI ROY, SAYON · 2015 to 2019
$2.2M
Osteoblast Dopamine Receptor Mediates Diabetic Bone DiseaseR21AR077260 · NIAMS · ADA FORSYTH INSTITUTE, INC. · PI TRACKMAN, PHILIP C · 2021 to 2022
$479k
Mechanism of Bone Marrow Neoplasm-Induced OsteosclerosisR21AR072748 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAVID, KATYA, TRACKMAN, PHILIP C · 2018 to 2019
$399k
NEI NIH HHS R01 EY025528NEI NIH HHS R01EY025528NIAMS NIH HHS R21 AR072748NIAMS NIH HHS R21 AR077260NIAMS NIH HHS R21AR077260
6 · The paper itself

Abstract

Lysyl oxidases are multifunctional proteins derived from five lysyl oxidase paralogues

Indexed as

Diabetes MellitusDiabetic RetinopathyNeoplasmsProtein-Lysine 6-OxidaseCollagenHumansPeptidesCollagenLOXL4 protein, humanPeptidesProtein-Lysine 6-Oxidasediabeteseye pathologieslysyl oxidaselysyl oxidase propeptidestructure–function

Identifiers

PMID35563478
PMCPMC9105217
OpenAlexW4225412770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.